Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol

References

• Wild S Roglic G Green A Sicree R King H Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 2004 27 5 1047 1053 15111519
   PubMed Web of Science ®Google Scholar
• Chan JC Malik V Jia W Diabetes in Asia: epidemiology, risk factors, and pathophysiology JAMA 2009 301 20 2129 2140 19470990
   PubMed Web of Science ®Google Scholar
• Brämer GR International statistical classification of diseases and related health problems. Tenth revision World Health Stat Q 1988 41 1 32 36 3376487
   PubMedGoogle Scholar
• Moore PA Zgibor JC Dasanayake AP Diabetes: a growing epidemic of all ages J Am Dent Assoc 2003 134 Spec 11S 15S 18196668
   PubMedGoogle Scholar
• Cani PD Neyrinck AM Fava F Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia Diabetologia 2007 50 11 2374 2383 17823788
   PubMed Web of Science ®Google Scholar
• Wu R Zhang W Liu B Probucol ameliorates the development of nonalcoholic steatohepatitis in rats fed high-fat diets Dig Dis Sci 2013 58 1 163 171 22878918
   PubMed Web of Science ®Google Scholar
• Yamashita S Matsuzawa Y Where are we with probucol: a new life for an old drug? Atherosclerosis 2009 207 1 16 23 19457483
   PubMed Web of Science ®Google Scholar
• Shimizu H Uehara Y Shimomura Y Tanaka Y Kobayashi I Probucol attenuated hyperglycemia in multiple low-dose streptozotocin-induced diabetic mice Life Sci 1991 49 18 1331 1338 1833606
   PubMed Web of Science ®Google Scholar
• Russell JC Graham SE Amy RM Dolphin PJ Cardioprotective effect of probucol in the atherosclerosis-prone JCR:LA-cp rat Eur J Pharmacol 1998 350 2–3 203 210 9696409
   PubMed Web of Science ®Google Scholar
• Parthasarathy S Young SG Witztum JL Pittman RC Steinberg D Probucol inhibits oxidative modification of low density lipoprotein J Clin Invest 1986 77 2 641 644 3944273
   PubMed Web of Science ®Google Scholar
• Matsushita M Yoshino G Iwai M Protective effect of probucol on alloxan diabetes in rats Diabetes Res Clin Pract 1989 7 4 313 316 2693032
   PubMed Web of Science ®Google Scholar
• Liu JH Liu DF Wang NN Lin HL Mei X Possible role for the thioredoxin system in the protective effects of probucol in the pancreatic islets of diabetic rats Clin Exp Pharmacol Physiol 2011 38 8 528 533 21615774
   PubMed Web of Science ®Google Scholar
• Blankenhorn DH Schettler G Habenicht A Principles and Treatment of Lipoprotein Disorders Berlin Springer 1994
   Google Scholar
• Buckley MM Goa KL Price AH Brogden RN Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia Drugs 1989 37 6 761 800 2667936
   PubMed Web of Science ®Google Scholar
• Jizomoto H Kanaoka E Sugita K Hirano K Gelatin-acacia microcapsules for trapping micro oil droplets containing lipophilic drugs and ready disintegration in the gastrointestinal tract Pharm Res 1993 10 8 1115 1122 8415395
   PubMed Web of Science ®Google Scholar
• Zimetbaum P Eder H Frishman W Probucol: pharmacology and clinical application J Clin Pharmacol 1990 30 1 3 9 2406299
   PubMed Web of Science ®Google Scholar
• Heeg JF Hiser MF Satonin DK Rose JQ Pharmacokinetics of probucol in male rats J Pharm Sci 1984 73 12 1758 1763 6527251
   PubMed Web of Science ®Google Scholar
• Chang TM Microencapsulation of enzymes, cells, and genetically engineered microorganisms Methods Mol Med 1999 18 315 330 21370187
   PubMedGoogle Scholar
• Chang TM Pharmaceutical and therapeutic applications of artificial cells including microencapsulation Eur J Pharm Biopharm 1998 45 1 3 8 9689530
   PubMed Web of Science ®Google Scholar
• Negrulj R Mooranian A Al-Salami H Potentials and limitations of bile acids in type 2 diabetes mellitus: applications of microencapsulation as a novel oral delivery system J Endocrinol Diabetes Mellitus 2013 1 2 49 59
   Google Scholar
• Whelehan M Marison IW Microencapsulation using vibrating technology J Microencapsul 2011 28 8 669 688 22047545
   PubMed Web of Science ®Google Scholar
• Al-Salami H Butt G Fawcett JP Tucker IG Golocorbin-Kon S Mikov M Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats Eur J Drug Metab Pharmacokinet 2008 33 2 101 106 18777945
   PubMed Web of Science ®Google Scholar
• Al-Salami H Butt G Tucker I Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats Eur J Drug Metab Pharmacokinet 2009 34 1 43 50 19462928
   PubMed Web of Science ®Google Scholar
• Al-Salami H Butt G Tucker I Mikov M Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics Methods Find Exp Clin Pharmacol 2008 30 2 107 113 18560625
   PubMedGoogle Scholar
• Al-Salami H The Influence of Pre-Treatment with Probiotics on the in Vitro Ileal Permeation of the Antidiabetic Drug Gliclazide, in Healthy and Diabetic Rats Drug Metab Rev 2008 40 81 82
   Web of Science ®Google Scholar
• Al-Salami H Butt G Tucker I Skrbic R Golocorbin-Kon S Mikov M Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats Arch Drug Inf 2008 1 1 35 41 20157366
   PubMedGoogle Scholar
• Lalić-Popović M Vasović V Milijašević B Goločorbin-Kon S Al-Salami H Mikov M Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat J Diabetes Res 2013 2013 598603 23671878
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulj R Mathavan S A complex microencapsulated system: a platform for optimised oral delivery of antidiabetic drug-bile acid formulations Pharm Dev Technol 2014 1 8 24798888
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulj R Mathavan S Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics J Pharm Innov 2014 9 150 157 24829616
   PubMed Web of Science ®Google Scholar
• Davignon J Probucol Principles and Treatment of Lipoprotein Disorders Berlin Springer 1994 429 469
   Google Scholar
• Awasthi R Kulkarni GT Development of novel gastroretentive floating particulate drug delivery system of gliclazide Curr Drug Deliv 2012 9 5 437 451 22920574
   PubMed Web of Science ®Google Scholar
• Prajapati SK Tripathi P Ubaidulla U Anand V Design and development of gliclazide mucoadhesive microcapsules: in vitro and in vivo evaluation AAPS PharmSciTech 2008 9 1 224 230 18446485
   PubMed Web of Science ®Google Scholar
• Yang Y Campanella OH Hamaker BR Zhang G Gu Z Rheological investigation of alginate chain interactions induced by concentrating calcium cations Food Hydrocoll 2013 30 1 26 32
   Web of Science ®Google Scholar
• de Celis Alonso B Rayment P Ciampi E NMR relaxometry and rheology of ionic and acid alginate gels Carbohydr Polym 2010 82 3 663 669
   Web of Science ®Google Scholar
• Draget KI Taylor C Chemical, physical and biological properties of alginates and their biomedical implications Food Hydrocoll 2011 25 2 251 256
   Web of Science ®Google Scholar
• Bonino CA Samorezov JE Jeon O Alsberg E Khan SA Real-time in situ rheology of alginate hydrogel photocrosslinking Soft Matter 2011 7 24 11510 11517
   Web of Science ®Google Scholar
• Pamies R Schmidt RR Martínez MCL Torre JG The influence of mono and divalent cations on dilute and non-dilute aqueous solutions of sodium alginates Carbohydr Polym 2010 80 1 248 253
   Web of Science ®Google Scholar
• Legrand J Dumont E Comiti J Fayolle F Diffusion coefficients of ferricyanide ions in polymeric solutions – comparison of different experimental methods Electrochim Acta 2000 45 11 1791 1803
   Web of Science ®Google Scholar
• Gardette JL Baba M FTIR and DSC studies of the thermal and photochemical stability of Balanites aegyptiaca oil (Toogga oil) Chem Phys Lipids 2013 170 171 1 7
   Web of Science ®Google Scholar
• Lin SY Wang SL Advances in simultaneous DSC-FTIR microspectroscopy for rapid solid-state chemical stability studies: some dipeptide drugs as examples Adv Drug Deliv Rev 2012 64 5 461 478 22300653
   PubMed Web of Science ®Google Scholar
• Sarmento B Ferreira D Veiga F Ribeiro A Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies Carbohydr Polym 2006 66 1 1 7
   Web of Science ®Google Scholar
• Gill P Moghadam TT Ranjbar B Differential scanning calorimetry techniques: applications in biology and nanoscience J Biomol Tech 2010 21 4 167 193 21119929
   PubMedGoogle Scholar
• Gerber JJ Caira MR Lötter AP Structures of two conformational polymorphs of the cholesterol-lowering drug probucol J Crystallogr Spectrosc Res 23 11 863 869
   Web of Science ®Google Scholar
• Ajun W Yan S Li G Huili L Preparation of aspirin and probucol in combination loaded chitosan nanoparticles and in vitro release study Carbohydr Polym 2009 75 4 566 574
   Web of Science ®Google Scholar
• Thybo P Pedersen BL Hovgaard L Holm R Mullertz A Characterization and physical stability of spray dried solid dispersions of probucol and PVP-K30 Pharm Dev Technol 2008 13 5 375 386 18720236
   PubMed Web of Science ®Google Scholar
• Takka S Cali AG Bile salt-reinforced alginate-chitosan beads Pharm Dev Technol 2012 17 1 23 29 20653409
   PubMed Web of Science ®Google Scholar
• Awasthi R Kulkarni GT Development of novel gastroretentive drug delivery system of gliclazide: hollow beads Drug Dev Ind Pharm 2014 40 3 398 408 23418961
   PubMed Web of Science ®Google Scholar